ClinicalTrials.govpublic full text
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
mutation, neoplasms, ctdna, high risk for developing cancer, plasma, relative risk, early detection of cancer, cancer screening tests, cancer screening, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895023
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.